Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News

  News Archive

Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
Friday, May 27, 2016
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.

Cigna to Cover NanoString's Prosigna® Breast Cancer Assay
Friday, May 27, 2016
NanoString Technologies has announced that Cigna has issued a positive Medical Coverage Policy decision for the Prosigna® Breast Cancer Gene Signature Assay.

QIAGEN Partners to Develop Predictive Tests in Oncology
Friday, May 27, 2016
Collaboration with Therawis addresses unmet need to guide clinical decisions in breast cancer.

Multiplicom Receives €1.9m Grant
Thursday, May 26, 2016
Multiplicom has received a Flanders Innovation & Entrepreneurship R&D grant of €1.9 million ($2.1 million) to support the development of advanced technologies and targeted NGS-based tests to enable early diagnosis, treatment and monitoring of cancers.

SCIENION, AXELA Partner on Array Development
Wednesday, May 25, 2016
Collaboration aims to jointly develop production systems and services for diagnostic and research products serving oncology, autoimmune, allergy, immunoassay, infectious disease and other markets.

Rosetta Receives Approval from NY State for Four PCR-Based Assays
Tuesday, May 24, 2016
BRAF, EGFR, KRAS and NRAS mutation detection assays now available in all 50 states.

Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Tuesday, May 24, 2016
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.

Making Virus Sensors Cheap and Simple
Tuesday, May 24, 2016
Researchers at The University of Texas at Austin demonstrated the ability to detect single viruses in a solution containing murine cytomegalovirus (MCMV).

Heart Defect Prediction Technology Could Lead to Earlier, More Informed Treatment
Tuesday, May 24, 2016
Experimental method uses genetics-guided biomechanics, patient-specific stem cells.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 2179
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!